Background: Hypertension is one of the leading causes of cardiovascular disease. Though many clinical guidelines published recently for the treatment of hypertension, there is substantial variation in the treatment of hypertension in different countries. Aims and objectives: To evaluate the drug utilization pattern among hypertensive patients and their adverse effects attending medicine OPD in a tertiary care teaching hospital. Materials and Methods: A prospective, observational study was conducted by Department of Pharmacology in a tertiary care teaching hospital over a period of six months. The diagnosis and line of treatment to be given was decided by the physician in charge of the Department of Medicine. All the information of ADR was recorded in CDSCO Suspected ADR reporting form. Results: Out of 600 patients, 43.83% were male and 56.17% were female. Maximum patients belonged to age group of 51-60 years (33.5%). Diabetes mellitus (40.33%) was the most common associated disease with hypertension. About half of the patients had received two antihypertensive drugs (49.50%), followed by one (33.16%) and three (15.5%) antihypertensive drugs. Enalapril was the most commonly prescribed antihypertensive drug (79.66%). 95 patients (15.83%) from the total of 600 patients developed ADR. Most common ADR was cough (18.94%) followed by headache (12.63%) and vomiting (10.52%). Enalapril was responsible for about half of the ADR (50.52%) followed by amlodipine (25.26%) and furosemide (25.26%). Conclusion: Rational utilization pattern of antihypertensive drugs was observed. However diuretics and calcium channel blockers prescribed less commonly. Most of the ADRs were probable (55.79%) and mild (30.53%).
INTRODUCTION
Hypertension is an important public health challenge in both economically developing and developed countries. In India, cardiovascular diseases (CVDs) are estimated to be responsible for 1.5 million deaths annually. [1] Hypertension is a major risk factor for CVDs, including stroke and myocardial infarction, and its burden is increasing disproportionately in developing countries as they undergo demographic transition. [2] A number of national and international guidelines for the treatment of hypertension have been published. JNC 7 guideline recommends diuretics as the first-line treatment in hypertension. [3] The European guideline, on the other hand, suggests that unless a special indication exists, any of the five antihypertensive classes can be used as first-line treatment. [4] The National Institute for Health and Clinical Excellence (NICE) guideline [5] recommend angiotensin-converting enzyme (ACE) inhibitor or angiotensin-II receptor blocker (ARB) as step 1 antihypertensive treatment aged under 55 years, whereas calcium channel blockers (CCBs) are preferred step 1 antihypertensive treatment aged over 55 years. A combination treatment has recently been recommended as first-line intervention, particularly in patients with severe hypertension. [3, 4] Changes over time in terms of recommended guidelines and innovations in drug formulations have resulted in modifications in prescription pattern of antihypertensive drugs in different countries.
Monitoring of prescriptions and drug utilization studies could identify the associated problems and provide feedback to prescriber. [6] Developing countries have limited funds available for healthcare and drugs and it becomes very important to prescribe drug rationally so that the available funds can be utilized optimally. [7] Drug utilization studies are powerful exploratory tools to ascertain the role of drugs in society. They create a sound socio-medical and healthy economic basis for healthcare decision making. [8] Drugs are double edged weapons. Drugs, no matter how safe and efficacious, are always coupled with inescapable risk of adverse reactions. Thus, drug safety assessment should be considered as an integral part of day to day clinical practice. Adverse drug reactions (ADRs) are considered among the leading causes of morbidity and mortality. Monitoring of ADRs is more important in case of chronic ailments such as hypertension. More often than not, hypertension is an asymptomatic disorder and requires long term therapy predisposing to adverse drug events. [9] The objective of present study was to focus on the trends in the drug utilization of antihypertensive drugs and to evaluate the clinical spectrum of all ADRs of antihypertensive drugs in the outpatients attending the Dept. of Medicine. It also emphasises the need and importance of an effective pharmacovigilance programme. 
MATERIALS AND METHODS
A prospective, observational study was conducted by Department of Pharmacology in association with Department of Medicine in a Guru Gobindsinh Government hospital, Jamnagar. The study was conducted over a period of 6 months from Dec 2011-May 2012 after approval from Institutional Ethics Committee. The diagnosis and line of treatment to be given was decided by the physician in charge of the Department of Medicine. No additional drugs or investigations were advised by us during the study period. Data of patients matching inclusion criteria were recorded after getting informed consent. Identity of patient was kept confidential. 
 Selection criteria of patients

Inclusion Criteria
Sample size
WHO recommends a sample size of at least 600 encounters for drug utilization studies (WHO how to investigate drug use in health facilities, 1993). [10] Based on above recommendation, we used a sample size consisting of 600 patients.
Collection of Data
Data of patients matching inclusion criteria were recorded. Before including in the study, patients were explained about the aspects of research work. Written informed consent was taken before including him or her into the study. Once the consultation by the physician was over, the prescriptions were copied and patients were interviewed regarding duration of taking antihypertensive drugs and detail of adverse drug reaction if developed. Data like name, age, sex, duration of hypertension, family history, vital data, general examination, laboratory investigation, concurrent diseases, and ongoing treatment was recorded from patient's case. These data were recorded in previously prepared case record forms. Total 600 cases were collected. Patients were included from all the six units of medicine. The diagnosis of the ADR was done by a consultant physician based on clinical and laboratory investigation data. ADR was defined as per the definition provided by WHO (1972) . [11] All the information of ADR was carefully recorded in CDSCO Suspected ADR reporting form. Causality, Severity and preventability of ADR were assessed by WHO causality assessment scale [12] , Hartwig and Siegel severity assessment scale [13] and Schumock and Thornton preventability scale [14] respectively.
All the data were compiled and subjected to descriptive statistical analysis using mean and standard deviation in Graph pad prism. Among the antihypertensive drugs, enalapril (ACE inhibitor) was the most commonly prescribed drug (79.66%) followed by atenolol (beta blocker) (49.66%), amlodipine(CCB) (33.83%), furosemide (loop diuretic) (17%) and metoprolol (beta blocker) (4.66%). Antidiabetic drugs were prescribed to 40.83% of patients. Among them, metformin was the most commonly prescribed drug (32.33%) followed by glibenclaimide (25.16%), insulin (7.50%), pioglitazone (5.83%), voglibose (2.33%) and acarbose(1.66%). Antiplatelets (aspirin and clopidogrel) were prescribed to 40.66% of patients. The statins (atorvastatin) were prescribed only to a small proportion of patients (8.33%). Other drugs prescribed were paracetamol (12.33%), cetrizine (10.33%), vitamins B complex and folic acid (9.83%), famotidine (9.66%) and alprazolam (6%) [ Table 2 ]. In present study 33.16% of patients had received single drug for the treatment of hypertension. 33.47% of diabetic patients associated with hypertension had received single drug for treatment. Enalapril was the most commonly used drug (21.16%) followed by atenolol (6.83%) and amlodipine (4.5%). Same utilization pattern was observed in patients of diabetes who had received enalapril (24.89%) most common drug followed by atenolol (5.30%) and amlodipine (3.26%) [ Table 3 ].
RESULTS
Out
Two drugs were prescribed in 49.50% of patients. 46.53% patients with diabetes were received two drugs. Enalapril + atenolol was most commonly prescribed combination (22%) followed by enalapril + amlodipine (10.83%) and enalapril + furosemide (5.33%). Same utilization pattern was observed in patient of diabetes who had received enalapril + atenolol combination (20.40%) followed by enalapril + amlodipine (9.79%) and enalapril + furosemide (5.71%) [ Table 3 ].
Three drugs were prescribed in 15.50% of patients. 13.46% patients with diabetes were received three drugs. Enalapril + atenolol + amlodipine was most commonly prescribed combination (8%) followed by enalapril + atenolol + furosemide (4.16%) and enalapril + amlodipine + furosemide (1.66%). Same utilization pattern was observed in patient of diabetes [ Table 3 ].
Four drugs were prescribed in 1.83% of patients. Enalapril + atenolol + amlodipine + furosemide were most commonly prescribed combination (1.66%). Same combination was prescribed in patients of diabetes (1.22%) [ Table 3 ]. Figure 1 ].
In present study most common SOC (System Organ Class) of ADRs involved was nervous system disorders (23.15%) followed by respiratory, thoracic and mediastinal disorders (18.94%), gastrointestinal disorders (15.78%) and general disorders and administration site disorders (13.68%). Most common ADR according to preferred term (PT) was cough (18.94%) followed by headache (12.63%), vomiting (10.52%), oedema peripheral (8.42%) and maculopapular rash (7.36%) [ Table 5 ].
In current study enalapril was responsible for about half of the ADR (50.52%) followed by amlodipine (25.26%), furosemide (25.26%) and atenolol (14.73%). Enalapril was mainly responsible for dry cough (18.94%) followed by gastrointestinal adverse effects (9.47%) and rash (7.36%). Most common ADR of amlodipine was headache (9.47%) followed by ankle edema (8.42%) and palpitation (6.31%). Most common ADR of furosemide was gastrointestinal adverse effects (9.47%) followed by fatigue and numbness (8.42%) and dizziness (5.26%). Atenolol was mainly responsible for bradycardia (6.31%) followed by hyperkalemia (3.15%) and headache (2.10%).
According to WHO causality assessment scale most of ADRs were "probable" (55.79%) followed by "possible" (35.79%) and certain (8.42%).
According to Hartwig and Siegel severity assessment scale 30.53% ADRs were "mild" and 69.47% ADRs were "moderate". According to Schumock and Thornton preventability scale 8.42% ADRs were "preventable" while 91.58% ADRs were "not preventable".
DISCUSSION
Hypertension is a chronic disease requiring lifelong treatment. Although lifestyle modifications play an important role in hypertension management, drugs become unavoidable in many patients. This study analysed the prescription pattern in hypertensive In present study 263 (43.83%) patients were male and 337 (56.17%) patients were female. Study conducted by Pai et al [15] reported 50.5% male and 40.5% female. Other study by Sandozi and Emani [16] has found 47% male and 53% female and Queen Mary Utilization of Antihypertensive Drugs Study (QUADS) [17] conducted in 2004 observed 48% male and 52% female in the study.
Most common age group involved in our study was 51-60 years (33.5%), followed by 61-70 years (26%) and 41-50 years (21.67%). Tiwari et al [18] also found most common age group 50-59 years (33.3%) followed by 60-69 years and 40-49 years(26.7%). Study conducted by Pai et al [15] reported most common age group 60-69 years (34%) followed by 70-79 years (23%) and 40-49 years (22%).
In current study, mean age of study subjects were 56.74±11.23 years with 58.11±10.94 years in male and 55.66±11.35 years in female. Pai et al [15] found mean age in study subject 63.1 years with 62.72 years in male and 63.48 years in female. Etuk et al [19] found mean age in study subject 52.3±14.6 years.
Patients with chronic diseases like hypertension usually suffer from other associated conditions. In our study, majority of the patients were suffering from concurrent diabetes (40.33%). Other associated conditions were angina (5.33%), COPD (5%), IHD (3.83%) and epilepsy (3.5%). Study conducted by Pai et al [15] reported diabetes mellitus (47.5%), ischemic heart disease (16.5%), hyperlipidemia (18%), renal diseases (7.5%) & cardiovascular accidents (16%) concurrently. Sakthi S et al [20] reported diabetes mellitus(35%) as the most frequent co-morbidity followed by asthma(5%) and ischemic heart disease(1.6%). Such patients are at greater risk of developing complications. Among the various diseases, cardiovascular diseases pose a major threat. Multiple drugs are required for their management. Polypharmacy is associated with a high cost, increased risk of side effects, drug interaction and noncompliance. [21] In current study, the average number of antihypertensive drugs per encounter was 1.86±0.73 with range of 1 to 4. QUADS [17] conducted in 2004 has reported 2.0±0.06 antihypertensive drugs per encounter. The average number of drugs per encounter was 4.01±1.61 in our study with range of 1 to 10. Sandozi and Emani [16] has reported 4.68 drugs per prescription and Akici et al [22] has reported 3.8±1.1 drugs per prescription. The observed difference might be because of different demographic profile of study patients, different prescribing practices and availability of drugs. Because hypertension is associated with various concurrent diseases and its complications, polypharmacy is quite prevalent. In this study, the number of drugs prescribed to patients is more for those who had longer duration of hypertension. 82% patients had received 3 or more drugs. 88.44% of patients who had more than 5 years of duration of hypertension had received 3 or more different drugs as compared to 77.36% of patients who had less than 5 years duration of hypertension. As the disease progresses, it is difficult to control the blood pressure and it requires combination of drugs.
Among the antihypertensive drugs, enalapril (ACE inhibitor) was the most commonly prescribed drug (79.66%) followed by atenolol (beta blocker) (49.66%), amlodipine (CCB) (33.83%), furosemide (loop diuretic) (17%) and metoprolol (Beta blocker) (4.66%). This is in consonance with study conducted by Sandozi and Emani [16] reported ACEIs (47%) were most commonly prescribed drug followed by CCBs (25.85%), beta blockers (12%), angiotensin receptor blockers (10.8%) and diuretics (3.7%). Other study conducted in India by Pai et al [15] reported calcium channel blockers (49%) were the most commonly prescribed drugs followed by diuretics (43.5%), angiotensin converting enzyme inhibitors (29.5%) beta blockers (29%), angiotensin receptor blockers (21%), alpha adrenergic blockers (2%) and central sympatholytics (2%). QUADS [17] reported CCB (65%) were the most commonly prescribed drugs followed by beta blockers (64%) and ACEIs (33%). This difference might be due to physician's choice with relation to the characteristics of patients, their concurrent illness, as well as the availability of medicines.
In present study enalapril (74.69%) was the most commonly prescribed antihypertensive drug in patients of associated diabetes mellitus followed by atenolol (41.63%), amlodipine (29.39%) and furosemide (13.06%). However, Pai et al [15] reported that diuretics (43.1%) were the leading class of drugs followed by the ACEI (40%), CCB (29.5%), beta blockers (26.3%) and ARB (17.9%) in patients of associated diabetes mellitus. Akici et al [16] found CCB (35.5%) were the leading class of drugs followed by the ACEI (25.8%), diuretics (9.7%) and beta blockers (9.7%) in diabetic patient.
In present study about half of the patients had received two antihypertensive drugs (49.50%), followed by one (33.16%), three (15.5%) and four (1.83%) antihypertensive drugs. Pai et al [15] reported monotherapy (49%) as most commonly prescribed pattern followed by two (34.5%), three (14%) and four drug (2.5%) regimen antihypertensive therapy. Etuk et al [19] found two drug combination (49.30%) most commonly followed by three (26.38%) one (20.13%) and four (94.16%) drug antihypertensive regimen.
Present study found enalapril + atenolol was most commonly prescribed two drug combinations (22%) followed by enalapril + amlodipine (10.83%) and enalapril + furosemide (5.33%). Pai et al [15] found ARB with diuretic (25.4%) was the most frequently prescribed two drug combination followed by a combination of two diuretics (10.8%) and CCB with beta blockers (9.8%). Etuk et al [19] reported ACEI and diuretic (19.44%) most common two drug combination followed by central sympatholytic and diuretic (11.11%) and CCB and diuretic (9.72%).
This study found enalapril + atenolol + amlodipine as most commonly prescribed three drug combinations (8%) followed by enalapril + atenolol + furosemide (4.16%) and enalapril + amlodipine + furosemide (1.66%). Etuk et al [19] reported ACEI + diuretic + central sympatholytic (13.88%) most commonly prescribed three drug combinations followed by ACEI + diuretic + CCB (4.16%) and ACEI + diuretic + beta blocker (3.47%).
In present study enalapril + atenolol + amlodipine + furosemide was most commonly prescribed four drug combination (1.66%). Etuk et al [19] reported ACEI + diuretic + CCB+ central sympatholytic (2.77%) as most commonly prescribed four drug combination.
The present study observed that multiple drug therapy (66.84%) was more common than single drug therapy (33.16%). These results supports the work of Hansson et al [15] reported that blood pressure could be adequately controlled with the help of combination therapy. Furthermore combination therapy seems to be a rational approach to reduce the cardiovascular mortality. [4] Diuretics are the recommended first-line treatment in the US (JNC VII) [3] guidelines. However, UK National Institute for Health and Clinical Excellence (NICE) guideline [5] on the management of primary hypertension in adults recommend angiotensinconverting enzyme (ACE) inhibitor or a low-cost angiotensin-II receptor blocker (ARB) as step 1 antihypertensive treatment aged under 55 years. While calcium channel blockers (CCBs) is preferred step 1 antihypertensive treatment aged over 55 years and advise that thiazide-like diuretics should only be used first line if CCBs are not suitable or if the patient has edema or has a high risk of developing heart failure. In our study diuretic (17%) and CCB (33.83%) were prescribed less frequently.
In this study, 74.22% drugs were given by generic name and 25.78% were given by brand name. It is clearly evident that more than 2/3rd of drugs were prescribed by generic name and therefore drug use in this set up is quite rational. Increasing generic prescribing would rationalize the use and reduce the cost of drugs. [23] Out of 43 drugs used, 32 (74.41%) drugs were prescribed from National list of essential medicines of India, 2011 and 33 (76.74%) drugs were prescribed from essential drug list of Gujarat, 2010-11, which points towards rational prescription practices. Use of drugs from the essential drug list should be promoted for optimal use of limited financial resources, to have acceptable safety and to satisfy the health needs of the majority of the population.
In present study antihypertensive drugs were prescribed for 30 days at each encounter. Average cost of antihypertensive drugs per encounter was ` 137.69 and average cost per encounter of all drugs including antihypertensive drugs was ` 243.33. The percentage of drug costs spent on antihypertensive is 56.58%. It is relatively higher in the study conducted in India by Jhaj et al [24] and Sandozi and Emani. [16] The higher cost in these studies is due to more drugs were prescribed by brand name as compared to generic name. Cost of prescription is important in chronic disease like hypertension. One of the better approaches to decrease the prescription cost is to prescribe cheaper brands. Since hypertension is a long term disease and drug has to be continued for life time, there is a reasonable scope in reducing the prescription cost by prescribing cheaper alternatives.
In current study prescribed daily dose of various antihypertensive drugs observed are as followsenalapril (10.14 mg), atenolol (80.37 mg), amlodipine (8.91 mg), furosemide (49.41 mg) and metoprolol (91.07 mg). PDD:DDD ratio ranged between 0.607-1.782 with amlodipine (CCB) having maximum ratio (1.782) followed by furosemide (loop diuretics) (1.235), atenolol (beta blockers) (1.071) and enalapril (1.014). Our result concluded that PDD:DDD for atenolol and enalapril is approximately 1 indicative of appropriate utilization pattern of these drugs. While PDD:DDD ratio of amlodipine (1.782) and furosemide (1.235) suggest overutilization of these antihypertensive drugs. Grimmsmann and Himmel [25] reported ACEIs had most notable PDD:DDD ratio (2.17), followed by the ARBs (1.88), CCB (1.51), thiazide diuretics (1) and beta blockers (0.84). Factors such as the severity of the hypertension or the doctor's dissatisfaction with the efficacy of a drug may lead to a change of drugs or change of dose-seem to be responsible for alteration of PDD:DDD ratio.
In present study 95 patients (15.83%) from the total of 600 patients developed ADR. Among them 48 (50.52%) were male and 47 (49.48%) were female. Our result is in consonance with Hussain et al [26] which reported ADR in 13.60% patients and Alomar and Strauch [27] reported ADR in 14.25% of patients. Hussain et al [26] found higher percentage of ADRs in females (58.8%) than males (41.2%).
In current study, ADRs were observed most commonly in age group of 61-70 years (37.89%) followed by 51-60 years (28.42%) and 41-50 years (17.89%). Hussain et al [26] observed most common age group 41-50 years (35.3%), followed by 51-60 years (26.5%) and 61-70 years (26.5%).
In current study most common SOC (System Organ Class) of ADRs involved was nervous system disorders (23.15%) followed by respiratory, thoracic and mediastinal disorders (18.94%), gastrointestinal disorders (15.78%) and general disorders and administration site disorders (13.68%). The previous studies by Hussain et al [26] reported cardiac disorders to be most frequent cause of ADRs (35.3%) followed by gastrointestinal disorders (20.6%).
In present study most common individual ADR was cough (18.94%) followed by headache (12.63%), vomiting (10.52%), peripheral oedema (8.42%) and maculopapular rash (7.36%). Our results are in accordance with Hussain et al [26] , reported cough as most common ADR followed by peripheral oedema, headache and hypotension. While Alomar and Strauch [27] found headache as most common ADR followed by gastrointestinal adverse reaction, fatigue and numbness, dizziness and oedema. Different type of ADRs observed is due to different prescription pattern of antihypertensive drugs in the study.
In current study enalapril (ACEIs) was responsible for about half of the ADR (50.52%) followed by amlodipine (CCB) (25.26%), furosemide (Diuretics) (25.26%) and atenolol (Beta blockers) (14.73%). This result is different with previous studies by Hussain et al [26] reported beta blockers (32.35%) is the most common group responsible for ADR followed by CCB (26.47%) and ACE inhibitors (14.70%) whereas Basak et al [28] reported CCB (38.01%) as most common group responsible for ADR followed by ACE inhibitors (23.14%) and beta blockers (21.07%). This difference is due to differences in prescription pattern of antihypertensive drugs in our study and these two studies.
In present study according to WHO causality assessment scale most of ADRs were "probable" (55.79%) followed by "possible" (35.79%) and "certain" (8.42%). Hussain et al [26] found most common ADRs were "possible" (47.1%), followed by "probable" (35.5%) and "certain" (2.9%). In our study most of ADRs were "probable" which suggest that these ADRs are due to antihypertensive drugs and are unlikely to be attributed to concurrent disease or other drugs or chemicals, and follows a clinically reasonable response on withdrawal (dechallenge) of antihypertensive drugs. "Possible" ADRs of antihypertensive drugs could also be explained by concurrent disease or other drugs or chemicals. While "certain" ADRs intimate that antihypertensive drugs are responsible for ADRs and it cannot be explained by concurrent disease or other drugs or chemicals. Also the response to withdrawal of the drug (dechallenge) is clinically plausible and the event is definitive pharmacologically using a satisfactory rechallenge if necessary.
According to Hartwig and Siegel severity assessment scale 30.53% ADRs were "mild" and 69.47% were "moderate" in our study whereas 52.9% ADRs were "mild", 41.2% were "moderate" and 5.8% were "severe" in Hussain et al [26] study.
Duration of present study was six month, which is one limitation of the study. Long duration of study may provide further information regarding utilization pattern and other rare adverse drug reaction of antihypertensive drugs.
CONCLUSION
This study provided a baseline data regarding the prescribing pattern in hypertensive patients. There is a scope for improvement, particularly the under utilization of diuretics and calcium channel blocker in the present drug utilization study of hypertension. Since hypertension is a common lifelong disorder, prescription cost is one of the major reasons for nonadherence to drug therapy. One of the important factors which affect compliance of patient and drug adherence is the presence of the adverse drug reactions. Further studies from time to time are required in drug utilization pattern and standard treatment guidelines to be circulated among prescribing physician.
